| Primary |
| Drug Use For Unknown Indication |
36.0% |
| Product Used For Unknown Indication |
18.0% |
| Pneumonia |
9.8% |
| Bronchitis |
4.5% |
| Pyrexia |
4.3% |
| Infection |
3.9% |
| Urinary Tract Infection |
3.7% |
| Pyelonephritis |
3.3% |
| Sepsis |
2.5% |
| Prophylaxis |
2.2% |
| Meningitis |
1.7% |
| Tonsillitis |
1.3% |
| Lung Infection |
1.2% |
| Meningitis Bacterial |
1.1% |
| Pain |
1.1% |
| Bronchopneumonia |
1.1% |
| Hypertension |
1.1% |
| Bronchopneumopathy |
1.1% |
| Pneumonia Mycoplasmal |
1.0% |
| Bacterial Infection |
1.0% |
|
| Renal Failure Acute |
10.2% |
| Rash |
7.3% |
| Urticaria |
7.3% |
| Toxic Epidermal Necrolysis |
6.8% |
| Thrombocytopenia |
6.2% |
| Anaphylactic Shock |
6.0% |
| Cholelithiasis |
6.0% |
| Stevens-johnson Syndrome |
5.9% |
| Vomiting |
5.0% |
| Pyrexia |
4.7% |
| Shock |
4.5% |
| Pancytopenia |
4.3% |
| Death |
4.0% |
| Liver Disorder |
3.4% |
| Pancreatitis |
3.4% |
| Renal Failure |
3.3% |
| Cytolytic Hepatitis |
2.9% |
| Dyspnoea |
2.9% |
| Hepatic Function Abnormal |
2.9% |
| Acute Generalised Exanthematous Pustulosis |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
28.9% |
| Drug Use For Unknown Indication |
16.8% |
| Pneumonia |
7.0% |
| Hypertension |
6.4% |
| Pyrexia |
5.1% |
| Unevaluable Event |
3.6% |
| Urinary Tract Infection |
3.3% |
| Ill-defined Disorder |
3.2% |
| Lung Disorder |
2.7% |
| Prophylaxis |
2.6% |
| Infection |
2.5% |
| Lung Infection |
2.3% |
| Pain |
2.3% |
| Sepsis |
2.2% |
| Bronchitis |
2.2% |
| Tonsillitis |
2.0% |
| Endocarditis |
2.0% |
| Bacterial Infection |
1.8% |
| Sedation |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
|
| Thrombocytopenia |
11.1% |
| Toxic Epidermal Necrolysis |
9.4% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
8.1% |
| Renal Failure Acute |
8.1% |
| Toxic Skin Eruption |
6.8% |
| Pyrexia |
5.8% |
| Stevens-johnson Syndrome |
5.8% |
| Urticaria |
5.8% |
| Vomiting |
4.5% |
| Anaphylactic Shock |
4.1% |
| Rash |
4.1% |
| White Blood Cell Count Increased |
4.1% |
| Drug Hypersensitivity |
3.4% |
| Neutropenia |
3.2% |
| Renal Failure |
3.0% |
| Rhabdomyolysis |
2.8% |
| Erythema Multiforme |
2.6% |
| Cytolytic Hepatitis |
2.4% |
| Septic Shock |
2.4% |
| Liver Disorder |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.4% |
| Drug Use For Unknown Indication |
18.9% |
| Prophylaxis |
6.5% |
| Pain |
6.2% |
| Hypertension |
5.4% |
| Pneumonia |
5.3% |
| Multiple Myeloma |
4.1% |
| Infection |
3.3% |
| Pyrexia |
2.9% |
| Nausea |
2.5% |
| Constipation |
2.4% |
| Urinary Tract Infection |
2.3% |
| Depression |
2.3% |
| Sepsis |
2.2% |
| Insomnia |
2.0% |
| Breast Cancer |
1.9% |
| Asthma |
1.8% |
| Anxiety |
1.7% |
| Osteoporosis |
1.5% |
| Bronchitis |
1.5% |
|
| Vomiting |
10.6% |
| Weight Decreased |
8.6% |
| Thrombocytopenia |
7.9% |
| Pyrexia |
6.5% |
| Pulmonary Embolism |
6.3% |
| Urinary Tract Infection |
6.2% |
| Renal Failure Acute |
5.9% |
| White Blood Cell Count Increased |
5.7% |
| Pneumonia |
5.0% |
| Sepsis |
4.2% |
| White Blood Cell Count Decreased |
4.0% |
| Wound Infection Staphylococcal |
3.6% |
| Varicella |
3.5% |
| Rhabdomyolysis |
3.4% |
| Wheezing |
3.4% |
| Weight Increased |
3.3% |
| Suicide Attempt |
3.2% |
| Neutropenia |
3.1% |
| Pain |
2.8% |
| Rash |
2.8% |
|
| Interacting |
| Hypertension |
19.8% |
| Drug Use For Unknown Indication |
12.8% |
| Product Used For Unknown Indication |
11.4% |
| Pneumonia |
7.4% |
| Chronic Obstructive Pulmonary Disease |
6.4% |
| Urinary Tract Infection |
5.4% |
| Helicobacter Infection |
4.0% |
| Pneumonia Bacterial |
3.4% |
| Psoriatic Arthropathy |
3.4% |
| Depression |
3.0% |
| Lung Disorder |
2.7% |
| Pain |
2.7% |
| Type 1 Diabetes Mellitus |
2.7% |
| Coronary Artery Disease |
2.3% |
| Hyperlipidaemia |
2.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.3% |
| Atrial Fibrillation |
2.0% |
| Localised Infection |
2.0% |
| Respiratory Tract Infection |
2.0% |
| Unevaluable Event |
2.0% |
|
| Drug Interaction |
29.3% |
| International Normalised Ratio Increased |
7.3% |
| Respiratory Failure |
7.3% |
| Clostridium Difficile Colitis |
4.9% |
| Enterocolitis |
4.9% |
| Gastrointestinal Inflammation |
4.9% |
| Hypokalaemia |
4.9% |
| Renal Failure Acute |
4.9% |
| Somnolence |
4.9% |
| Abdominal Wall Haematoma |
2.4% |
| Anxiety |
2.4% |
| Cytomegalovirus Test Positive |
2.4% |
| Enterocolitis Haemorrhagic |
2.4% |
| Haematoma |
2.4% |
| Haemorrhoids |
2.4% |
| Proteus Infection |
2.4% |
| Pyrexia |
2.4% |
| Respiratory Acidosis |
2.4% |
| Rhabdomyolysis |
2.4% |
| Staphylococcal Infection |
2.4% |
|
